Immunotherapy Cell Patent - Memorial Sloan Kettering
Summary
The European Patent Office published patent application EP4007586A1 for Memorial Sloan Kettering Cancer Center, covering cells for improved immunotherapy and their uses. The patent designates multiple European states including DE, FR, GB, IT, NL, and others. This is a routine patent publication notice for a cancer immunotherapy technology developed by David A. Scheinberg and Leila Peraro.
What changed
The EPO published patent EP4007586A1 (filed as EP4007586) for Memorial Sloan Kettering Cancer Center and affiliated institutions, covering immunotherapy cells and therapeutic uses thereof. The application includes IPC classifications spanning cell therapy (C12N 5/0783), antibodies (C07K 16/28), and related pharmaceutical compositions. The designated contracting states include all major European jurisdictions.
Patent publication notices do not impose compliance obligations. Entities conducting immunotherapy research or developing CAR-T or related cell therapies should review the patent claims to assess potential freedom-to-operate implications in the European market. No action is required based solely on this publication.
What to do next
- Review patent claims EP4007586A1 to assess freedom to operate in European immunotherapy markets
- Monitor EPO register for any opposition period following formal grant
Source document (simplified)
CELLS FOR IMPROVED IMMUNOTHERAPY AND USES THEREOF
Publication EP4007586A1 Kind: A1 Mar 25, 2026
Applicants
Memorial Sloan Kettering Cancer Center, Sloan-Kettering Institute for
Cancer Research, Memorial Hospital for Cancer and Allied
Diseases
Inventors
SCHEINBERG, David, A., PERARO, Leila
IPC Classifications
A61K 35/15 20150101AFI20230816BHEP A61K 35/17 20150101ALI20230816BHEP A61K 38/43 20060101ALI20230816BHEP A61K 38/46 20060101ALI20230816BHEP C07K 14/725 20060101ALI20230816BHEP C07K 16/28 20060101ALI20230816BHEP A61K 38/00 20060101ALI20230816BHEP A61K 39/00 20060101ALI20230816BHEP C12N 5/0783 20100101ALI20230816BHEP C12N 9/64 20060101ALI20230816BHEP
Designated States
AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR
Named provisions
Related changes
Source
Classification
Who this affects
Taxonomy
Browse Categories
Get Pharma & Drug Safety alerts
Weekly digest. AI-summarized, no noise.
Free. Unsubscribe anytime.
Get alerts for this source
We'll email you when ChangeBridge: EPO Bulletin - Biotech (C12N) publishes new changes.